Emergence of daptomycin non-susceptible coagulase-negative Staphylococci in patients with cardiovascular device infections
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000013487
Abstract: Rationale: Daptomycin (DAP) is a key drug for treating severe Staphylococcus infections. The emergence of DAP non-susceptible Staphylococcus aureus has been widely recognized in clinical situations, although the clinical status of DAP non-susceptible coagulase-negative Staphylococcus… read more here.
Keywords: non; non susceptible; dap non; cardiovascular device ... See more keywords